202_Right_Shot. png
Checked
Karte
13
AED2.700.000
Geschätzte Zahlung AED 11,1 Tsd./Monat
Finanzierung prüfen
Binghatti Ghost, Dubai Healthcare City Phase 2, Dubai
3 Schlafzimmer
4 Bäder
163 m²

Wohnung in Dubai Healthcare City Phase 2,Binghatti Ghost, 3 schlafzimmer, 2700000 AED - 17047598


This 3-bedroom apartment for sale in Binghatti Ghost is located in Dubai Healthcare City Phase 2, Al Jaddaf. The unit offers a practical layout with four bathrooms and a well-planned living and dining area. Large windows and a balcony provide extensive city and community views, including the Burj Khalifa.

Key Features:
  • 3 Bedrooms
  • 4 Bathrooms
  • Unfurnished
  • Balcony
  • Burj Khalifa view
  • Downtown city view
  • Community and pool views
  • Covered parking
  • 24-hour security
  • High-speed elevators

Additional Property & Building Features:
  • Adult swimming pool
  • Children’s pool
  • Gym and fitness center
  • Jogging and walking tracks
  • Kids’ play area
  • BBQ area
  • Multi-purpose lawn
  • Ground-floor retail center
  • Smart home capabilities
  • Maintenance services

This apartment is set within a wellness-focused community in Dubai Healthcare City Phase 2, offering convenient access to parks and healthcare facilities. It is approximately 3 minutes’ drive to Downtown Dubai and Dubai Mall, around 7 minutes to Ras Al Khor Wildlife Sanctuary, and about 9 minutes to Dubai Festival City Mall. The building is also located close to the metro, providing straightforward connectivity across Dubai.

Objektinformationen

  • TypWohnung
  • ZweckVerkauf
  • Referenznr.Bayut - 106134-KSKGBx
  • FertigstellungBezugsfertig
  • MöblierungUnmöbliert
  • Durchschnittsmiete
  • Hinzugefügt am31. Oktober 2026

Validierte Informationen

Validated Check Mark Icon

Hypothek

Berechne und sieh dir die monatliche Hypothek für diese Wohnung an

Gebäudeinformationen

Validated Check Mark Icon

Merkmale / Ausstattung

Wasserblick
Notstromversorgung
Zentralklimaanlage

Vergleichbare Abschlüsse

Validated Check Mark Icon

Trends & Indizes

Regulatorische Informationen

Für Sie empfohlen